Directing evolution: the next revolution in drug discovery?

Area of Science:

• Drug discovery and development
• Chemical biology
• Molecular biology

Background:

• Challenging drug targets like protein-protein interactions require novel screening strategies.
• Natural products, shaped by evolution, are a valuable source of bioactive compounds.
• Recent advances provide new opportunities to leverage evolutionary pressure for drug discovery.

Purpose of the Study:

• To describe innovations in directed-evolution strategies for drug discovery.
• To highlight examples of harnessing evolutionary pressure to identify and optimize compounds.
• To discuss remaining challenges and scientific gaps in applying directed evolution to drug discovery.

Main Methods:

• Utilizing DNA-encoded libraries for broader chemical space searching.
• Screening natural products with known biosynthetic pathways.
• Employing synthetic biology and biosensors to detect target molecules.
• Applying directed-evolution concepts to identify and optimize bioactive compounds.

Main Results:

• Innovations in key components of directed-evolution strategies have been described.
• Pioneering examples demonstrate the potential of directed evolution in identifying drug candidates.
• The study highlights the feasibility of using evolutionary pressure for compound optimization.

Conclusions:

• Directed evolution presents a promising approach for discovering and optimizing drugs against challenging targets.
• Further research is needed to address scientific gaps and fully realize the potential of directed evolution in drug discovery.
• Integrating advances in biosynthesis, synthetic biology, and biosensors can accelerate the development of novel therapeutics.